Routine Blood Tests and Colorectal Cancer: BIOCAN Poster at HMS2RC in Zagreb

Our research associate Andrijana Radović presented a poster at the 2nd Regional Congress HDIR–MOKAD–SDIR (HMS2RC) and the 8th Meeting of the Croatian Association for Cancer Research (HDIR-8), held in Zagreb, Croatia, on 4–5 November 2026.

The poster, titled “Multivariate profiling of routine laboratory parameters reveals coordinated systemic patterns across colorectal neoplasia”, was authored by Andrijana Radović, Janja Rašović, Damir Muhović, Aleksandra Klisic, Aleksandar Kujović, Batrić Vukčević and Maša Ždralević.

The study examined whether routine blood tests, which almost every patient already has, show a recognizable pattern in colorectal cancer. Instead of looking at single parameters, the team analyzed them together. Patients with colorectal cancer showed a combined pattern of anemia and inflammation, and both components were independently associated with the disease. Inflammatory changes were already present at the adenoma (precancerous) stage, while the anemia pattern appeared only in cancer. Because these tests are inexpensive and widely available, such patterns could help with colorectal cancer risk assessment.

This was Andrijana’s very first poster presentation and presenting at a congress for the first time is always a special experience. It is a chance to share your work, answer questions and learn from colleagues. Here’s to new challenges ahead!

Prof. Đuranović at the Days of Scientific Diaspora

On 15–16 October 2026, the University of Montenegro in Podgorica hosted the 5th International Scientific Symposium “Days of Scientific Diaspora 2026“, where Prof. Sergej Đuranović from Brown University, a member of the BIOCAN research team, gave a talk.

In his talk, “RAPPL-Seq provides insights into protein synthesis from clinically relevant samples“, Prof. Đuranović presented a new approach to ribosome profiling, a method that shows which proteins a cell is actively producing. Unlike conventional approaches, RAPPL-Seq requires only small amounts of biological material, which makes it suitable for patient samples.

The method uses magnetic bead-based affinity capture to efficiently isolate ribosome-protected RNA fragments. It was applied to biopsy samples of glioblastoma and adjacent non-tumour brain tissue, demonstrating its potential for studying protein synthesis directly in clinical material.

The research is associated with an international patent application filed by Washington University in St. Louis, with Prof. Đuranović named as one of the co-inventors.

We are proud to have Prof. Đuranović as part of the BIOCAN team and congratulate him on his excellent presentation.

BBMRI-ERIC officially welcomes Montenegro

On 15 October 2026, BBMRI-ERIC, the European research infrastructure for biobanking and biomolecular resources, officially announced that Montenegro, Portugal and Ukraine have joined the infrastructure. Portugal joined as a Member, while Montenegro and Ukraine joined as Observer countries.

As we reported in June (https://biocan.ucg.ac.me/2026/06/30/montenegro-becomes-an-observer-in-the-european-biobanking-infrastructure-bbmri-eric/), Montenegro was granted Observer status at the BBMRI-ERIC General Assembly. The Faculty of Medicine of the University of Montenegro is the national contact institution, and the BIOCAN biobank is the country’s central operational biobanking structure.

In the announcement, Dr Maša Ždralević, National Node Director, said that “Montenegro’s key strength lies in the opportunity to develop an integrated national biobanking ecosystem.”

With this enlargement, BBMRI-ERIC brings together 28 Member and Observer countries, plus IARC/WHO.

Read the full announcement: https://www.bbmri-eric.eu/news-events/montenegro-portugal-and-ukraine-join-bbmri-eric/

BIOCAN Researchers Presented Their Work at ICIMTH 2026 in Athens

Our team members from the University of Donja Gorica (UDG), Prof. Dr. Ramo Šendelj and Prof. Dr. Ivana Ognjanović, represented the project at the International Conference on Informatics, Management and Technology in Healthcare (ICIMTH 2026), held in Athens, Greece, on July 3–4, 2026.

At the conference, the team presented the paper “Understanding Biomedical Researchers’ Expectations of Biobanks: Experience in Montenegro,” exploring researchers’ expectations and needs regarding the organization and functioning of biobanks, based on experiences and challenges within Montenegro’s national research context. The topic is directly linked to the project’s work on establishing standardized procedures for the collection, processing, storage, and management of biological samples and data.

The presentation strengthened the international visibility of the BIOCAN project and enabled valuable exchange with the broader community of researchers in biomedical informatics, biobanking, and translational research.

Dr Maša Ždralević Awarded Fulbright Visiting Scholar Grant

We are pleased to announce that Dr Maša Ždralević has been awarded the prestigious Fulbright Visiting Scholar grant for a six-month research stay at the University of Texas MD Anderson Cancer Center, USA, supported by the U.S. Embassy in Podgorica. The Fulbright Visiting Scholar program is intended for established researchers with clearly defined, internationally relevant research plans, and is awarded according to strict criteria of scientific excellence.

Her research project, “Harnessing Tumor and Circulating-Free DNA Methylation for Prognosis and Treatment Stratification in Adenoid Cystic Carcinoma,” will analyze epigenetic DNA methylation patterns in tumor tissue and circulating free DNA to identify prognostic biomarkers for this rare and heterogeneous malignancy.

The results are expected to advance the molecular understanding of the disease and lay the groundwork for future translational research, international collaborations, and potential clinical applications.

Our Researchers Lecture at CANU Symposium

As part of its ongoing efforts to promote translational research in oncology, our active researchers contributed to the symposium “Malignant Tumors of the Head and Neck – Current Developments,” organized by the Montenegrin Academy of Sciences and Arts (CANU) on December 15, 2025. Prof. Dr. Ljiljana Vučković delivered a lecture titled “Molecular Pathology in the Diagnosis of Head and Neck Tumors,” while Dr. Maša Ždralević presented “Liquid Biopsies and Epigenetics – Opportunities and Challenges in the Diagnosis of Rare Tumors.”

The lectures addressed contemporary concepts in molecular pathology, liquid biopsies, and epigenetic approaches to tumor diagnostics, directly relevant to the scientific framework of the BIOCAN project.

Young researcher training in biobanking

We are pleased to share that Andrijana Konatar, our young research associate and PhD student, attended TRANSLACORE Biobanking Training School, hosted by the Izmir Biomedicine and Genome Center (IBG) from June 10-12. This event was supported within the scope of the CA 21154-TRANSLACORE COST project (www.translacore.eu).


During this three-day event, Andrijana participated in a series of activities including presentations, case studies, interactive panel discussions, and hands-on training sessions conducted by distinguished experts in the field. The training enabled Andrijana to gain basic biobanking skills, learn about the collection, processing, and storage of high-quality human biological samples, which is a very important step in effective cancer research, and of particular importance to the activities within BIOCAN project.

BIOCAN at Grant Awards Ceremony

Ministry of Education, Science and Innovation of Montenegro organized a ceremony for scientific grants recipients. The event took place on 20 Jan 2024. There was around 100 applications in the call. There were 89 eligible applications, and 22 applications were granted funding for the research and scientific capacity building. BIOCAN project was one of them.

Grant recipients with prof. Andjela Jaksic Stojanovic, Minister
Prog. Miodrag Radunovic represented the BIOCAN at the Ceremony